Uptake and Competition Among Biosimilar Biological Products in the US Medicare Fee-for-Service Population

J Gen Intern Med. 2022 Dec;37(16):4292-4294. doi: 10.1007/s11606-022-07670-7. Epub 2022 Jun 1.
No abstract available

Publication types

  • Letter
  • Research Support, U.S. Gov't, P.H.S.
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Aged
  • Biosimilar Pharmaceuticals*
  • Economic Competition
  • Fee-for-Service Plans
  • Humans
  • Medicare*
  • United States

Substances

  • Biosimilar Pharmaceuticals